Alpha-synuclein mechanism contributing to Parkinson’s disease revealed

Written by Adam Price-Evans

Musculoskeletal disorders are injuries or pain in the human musculoskeletal system, including the joints, ligaments, muscles, nerves, tendons, and structures that support limbs, neck and back.

Researchers at the University of Pittsburgh (PA, USA) led by J. Timothy Greenamyre (University of Pittsburgh ) appear to have elucidated the mechanism by which alpha-synuclein causes neurotoxicity in Parkinson’s disease (PD) brains. The findings were published recently in Science Translational Medicine. PD is a progressive neurodegenerative disease with motor symptoms including tremor, rigidity, bradykinesia and postural instability. A key pathological feature of PD is the selective loss of dopaminergic neurons in the brain, accompanied by the formation of alpha-synuclein rich Lewy body protein aggregates. High levels of alpha-synuclein have also been linked to the disruption  of normal mitochondrial functioning,...

To view this content, please register now for access

It's completely free